Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : STEM -- StemCells, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Kevin McKenzie who wrote (119)	11/14/1998 10:29:00 PM
From: Val77	Read Replies (1) \| Respond to of 805

Regarding the Businessweek Article, " But other companies may already have found a quicker route to these marvels.Already, Baltimore -based Osiris Therapeutic Inc. has regenerated bone in animals using another type of stem cell. And in Lincoln,R.I. , CytoTherapeutics Inc. plans to treat Parkinson's disease using a neural stem cell. " We're not talking about something 10 to 20 years away, like GERON, " says CEO Richard M. Rose, MD. Says James D McCament, editor of Medical Technology Stock Letter, "CytoTherapeutics is much closer to the clinic and more significant from an investment standpoint" Copyright 1998 The McGraw-Hill Companies